|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-2-8
|
|
pubmed:abstractText |
Metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is a cause of life-threatening infections. With parenteral colistin not available in Japan, we treated MDR P. aeruginosa sepsis with monobactam and aminoglycoside combination therapy, with screening using a 'break-point checkerboard plate'.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1651-1980
|
|
pubmed:author |
pubmed-author:AraokaHidekiH,
pubmed-author:Asano-MoriYukiY,
pubmed-author:BabaMasaruM,
pubmed-author:IshiwataKazuyaK,
pubmed-author:MasuokaKazuhiroK,
pubmed-author:MatsunoNaofumiN,
pubmed-author:NakanoNobuakiN,
pubmed-author:SeoSachikoS,
pubmed-author:TakagiShinsukeS,
pubmed-author:TaniguchiShuichiS,
pubmed-author:TsujiMasanoriM,
pubmed-author:UchidaNaoyukiN,
pubmed-author:WakeAtsushiA,
pubmed-author:YamamotoHisashiH,
pubmed-author:YoneyamaAkikoA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
231-3
|
|
pubmed:meshHeading |
pubmed-meshheading:20001223-Aminoglycosides,
pubmed-meshheading:20001223-Anti-Bacterial Agents,
pubmed-meshheading:20001223-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:20001223-Drug Therapy, Combination,
pubmed-meshheading:20001223-Female,
pubmed-meshheading:20001223-Humans,
pubmed-meshheading:20001223-Japan,
pubmed-meshheading:20001223-Male,
pubmed-meshheading:20001223-Microbial Sensitivity Tests,
pubmed-meshheading:20001223-Middle Aged,
pubmed-meshheading:20001223-Monobactams,
pubmed-meshheading:20001223-Pseudomonas Infections,
pubmed-meshheading:20001223-Pseudomonas aeruginosa,
pubmed-meshheading:20001223-Sepsis,
pubmed-meshheading:20001223-Treatment Outcome,
pubmed-meshheading:20001223-beta-Lactamases
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
